Novus Biologicals products are now on bio-techne.com

CARD10 Products

Antibodies
CARD10 Antibody
CARD10 Antibody
NBP1-33042
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC
Host: Rabbit Polyclonal
CARD10 Antibody - BSA Free
CARD10 Antibody - BSA Free
NBP2-92911
Species: Hu, Mu, Rt
Applications: WB, IHC
Host: Rabbit Polyclonal
Formulation Catalog # Availability Price  
CARD10 Antibody (HL2260) - Az ...
CARD10 Antibody (HL2260) - Azide a...
NBP3-25395
Species: Hu, Mu
Applications: WB, IHC
Host: Rabbit Monoclonal
Lysates
CARD10 Overexpression Lysate
CARD10 Overexpression Lysate
NBL1-08694
Species: Hu
Applications: WB
Proteins
CARD10 Recombinant Protein An ...
CARD10 Recombinant Protein Antigen
NBP2-55720PEP
Species: Hu
Applications: AC
CARD10 Antibody Blocking Pept ...
CARD10 Antibody Blocking Peptide
NBP1-76676PEP
Species: Hu
Applications: AC

Description

The caspase recruitment domain (CARD) is a protein module that consists of 6 or 7 antiparallel alpha helices. It participates in apoptosis signaling through highly specific protein-protein homophilic interactions. CARDs induce nuclear factor kappa-B (NFKB; MIM 164011) activity through the IKK (e.g., IKBKB; MIM 603258) complex. CARD9 (MIM 607212), CARD10, CARD11 (MIM 607210), and CARD14 (MIM 607211) interact with BCL10 (MIM 603517) and are involved in NFKB signaling complexes. Except for CARD9, these CARD proteins are members of the membrane-associated guanylate kinase (MAGUK) family.

Bioinformatics

Entrez Human
Uniprot Human
Human
Human
Human
Product By Gene ID 29775
Alternate Names
  • CARD-containing MAGUK 3 protein
  • CARD-containing MAGUK protein 3
  • Carma 3
  • CARMA3BIMP1Bcl10 binding protein and activator of NFKB
  • caspase recruitment domain family, member 10
  • caspase recruitment domain-containing protein 10
  • MGC142219

Research Areas for CARD10

Find related products by research area and learn more about each of the different research areas below.

Apoptosis

Related CARD10 Blog Posts

Check out the latest blog posts on CARD10.
Toll-like receptor 2 activation contributes to oral squamous cell carcinoma development and miRNA-mediated drug resistance
By Jamshed Arslan, Pharm. D., PhD. Squamous cell carcinoma is the most common cancer in the oral cavity.1 The tumor surface biofilms in oral cancers contain high levels of aerobic and anaerobic microorganisms.1,2 Peri...    Read more.
Read more CARD10 related blogs.